VaxInnate
A company developing vaccines for flu, malaria, dengue, papillomavirus and respiratory syncytial virus
2
Funding Rounds
$70.0m
Money raised
Overview
A company developing vaccines for flu, malaria, dengue, papillomavirus and respiratory syncytial virus
- Website:
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company VaxInnate has raised a total of $70m in funding over 2 rounds.
Key Insights:
- VaxInnate Series D round: $30m
- VaxInnate Series C round: $40m
VaxInnate Series D round
$30m
VaxInnate Series C round
$40m
Industries
VaxInnate is active in the following industries: